KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Idexx Laboratories (IDXX) Long-Term Debt Repayments (2019 - 2020)

Idexx Laboratories has reported Long-Term Debt Repayments over the past 2 years, most recently at $121.9 million for Q3 2020.

For Q3 2020, Long-Term Debt Repayments rose 453.91% year-over-year to $121.9 million; the TTM value through Sep 2021 reached $62.7 million, changed N/A, while the annual FY2020 figure was $289.6 million, 162.64% up from the prior year.
Long-Term Debt Repayments for Q3 2020 was $121.9 million at Idexx Laboratories, up from -$59.3 million in the prior quarter.
Over five years, Long-Term Debt Repayments peaked at $121.9 million in Q3 2020 and troughed at -$59.3 million in Q4 2019.